Improving predictability and transparency in DEA and FDA regulation
Subtitle: hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 7, 2014
Publisher: U.S. Government Publishing Office
Published: 2015
Place of publication: Washington
Language: eng
Number of pages: 217
Subjects: Drugs of abuse; Drugs; Law and legislation; Drug accessibility; Drug approval
Notes: Shipping list no.: 2015-0330-P.

"Serial No. 113-147."

Includes bibliographical references.